Publicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (20)

2023

  1. Somatic mutations in tumor and plasma of locoregional recurrent and/or metastatic head and neck cancer using a next-generation sequencing panel: A preliminary study

    Cancer Medicine, Vol. 12, Núm. 6, pp. 6615-6622

2022

  1. Emerging Blood-Based Biomarkers for Predicting Immunotherapy Response in NSCLC

    Cancers, Vol. 14, Núm. 11

  2. Real-world data with afatinib in Spanish patients with treatment-naïve non-small-cell lung cancer harboring exon 19 deletions in epidermal growth factor receptor (Del19 EGFR): Clinical experience of the Galician Lung Cancer Group

    Cancer Treatment and Research Communications, Vol. 33

2021

  1. Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture

    Nature Communications, Vol. 12, Núm. 1

  2. Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group

    Journal of Geriatric Oncology, Vol. 12, Núm. 3, pp. 410-415

  3. Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers

    Clinical and Experimental Metastasis, Vol. 38, Núm. 2, pp. 239-251

2020

  1. Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies

    Frontiers in Oncology, Vol. 10

  2. Re: Inhibition of a G9a/DNMT Network Triggers Immune-Mediated Bladder Cancer Regression

    Journal of Urology

2019

  1. CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status

    Clinical Cancer Research, Vol. 25, Núm. 1, pp. 390-402

  2. CTCs expression profiling for advanced breast cancer monitoring

    Cancers, Vol. 11, Núm. 12

  3. Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen

    Annals of Oncology, Vol. 30, pp. iv42-iv43

  4. Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet

    Frontiers in Genetics, Vol. 10

  5. Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status

    Scientific Reports, Vol. 9, Núm. 1

  6. Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression

    Nature Medicine

  7. Is there any affordable and reliable score in local gastric cancer?

    Annals of Oncology, Vol. 30, pp. iv60

2018

  1. The Ras-related gene ERAS is involved in human and murine breast cancer

    Scientific Reports, Vol. 8, Núm. 1

2016

  1. Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia)

    Oncology Letters, Vol. 12, Núm. 2, pp. 1403-1407

2014

  1. P21 suppresses inflammation and tumorigenesis on pRB-deficient stratified epithelia

    Oncogene, Vol. 33, Núm. 37, pp. 4599-4612

2010

  1. Cáncer de ovario. Enfermedad platino resistente

    Revisiones en Cancer, Vol. 24, Núm. 6, pp. 253-262

2007

  1. Derrame pleural tipo trasudado como expresión de afectación pleural por amiloidosis

    Revista Clinica Espanola